Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0307 | 1 | 0.5 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0061 | 0 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0307 | 1 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0165 | 0.4247 | 0.6286 |
Giardia lamblia | Kinase, CMGC CLK | 0.0061 | 0 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0158 | 0.3931 | 0.5818 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0227 | 0.6756 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0061 | 0 | 0.5 |
Leishmania major | protein kinase, putative | 0.0061 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0061 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0165 | 0.4247 | 0.6286 |
Brugia malayi | Protein kinase domain containing protein | 0.0158 | 0.3931 | 0.5818 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0158 | 0.3931 | 0.5818 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0307 | 1 | 1 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0158 | 0.3931 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0158 | 0.3931 | 0.5818 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0307 | 1 | 0.5 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0158 | 0.3931 | 0.5818 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0061 | 0 | 0.5 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0227 | 0.6756 | 1 |
Leishmania major | protein kinase, putative | 0.0061 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0165 | 0.4247 | 0.6286 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0158 | 0.3931 | 0.5818 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0227 | 0.6756 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0061 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0307 | 1 | 0.5 |
Trypanosoma brucei | kinetoplastid kinetochore protein 10 | 0.0061 | 0 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0307 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0307 | 1 | 0.5 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0227 | 0.6756 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0227 | 0.6756 | 1 |
Trypanosoma brucei | kinetoplastid kinetochore protein 19 | 0.0061 | 0 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.0061 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0158 | 0.3931 | 0.5818 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.